Conflict of Interest Disclosures Barcelona 2016

/Conflict of Interest Disclosures Barcelona 2016
Conflict of Interest Disclosures Barcelona 2016 2017-06-27T13:05:51+00:00

Conflict of Interest (CoI) Disclosures

 

The following members of the faculty and/or scientific committee disclose potential conflicts of interest:

 

Bonaventura Clotet has received research support grants, and fees as consultant and speaker from ViiV Healthcare and Merck Sharp & Dohme Corp.

Eugènia Negredo has received research support grants, and fees as consultant and speaker from ViiV Healthcare and Merck Sharp & Dohme Corp.

Roger Paredes has received research support grants and fees as consultant from ViiV Healthcare and Merck Sharp & Dohme Corp.

Jonathan Schapiro has received research support grants or fees as speaker or consultant from ViiV Healthcare and Merck Sharp & Dohme Corp.

Pedro Cahn has received research support grants, and fees as consultant and speaker from ViiV Healthcare and Merck Sharp & Dohme Corp.

Jürgen Rockstroh has received fees as consultant or speaker at educational events from ViiV Healthcare and Merck Sharp & Dohme Corp.

Giovanni Guaraldi has received research support grants from Merck Sharp & Dohme Corp, and fees as consultant and speaker from ViiV Healthcare and Merck Sharp & Dohme Corp.

Marc Noguera has no actual or potential conflict of interest to report

Daniele Armenia has no actual or potential conflict of interest to report

David Back has received research support grants, and fees as consultant and speaker from ViiV Healthcare and Merck Sharp & Dohme Corp.

Patrick Mallon has received fees as speaker or consultant from ViiV Healthcare

Peter Reiss has received research support grants from ViiV Healthcare and Merck Sharp & Dohme Corp.

Catherine M. Jankowski has no actual or potential conflict of interest to report

Julià Blanco has no actual or potential conflict of interest to report

Scott Letendre has received fees as consultant and speaker from ViiV Healthcare and Merck Sharp & Dohme Corp.

Cristina Tural has received fees as a speaker from Merck Sharp & Dohme Corp.

José Antonio Serra Rexach has no actual or potential conflict of interest to report